ATE255109T1 - Imidazopyridinderivate als gaba rezeptor liganden - Google Patents

Imidazopyridinderivate als gaba rezeptor liganden

Info

Publication number
ATE255109T1
ATE255109T1 AT00956700T AT00956700T ATE255109T1 AT E255109 T1 ATE255109 T1 AT E255109T1 AT 00956700 T AT00956700 T AT 00956700T AT 00956700 T AT00956700 T AT 00956700T AT E255109 T1 ATE255109 T1 AT E255109T1
Authority
AT
Austria
Prior art keywords
receptor ligands
gaba receptor
imidazopyridine derivatives
derivatives
imidazopyridine
Prior art date
Application number
AT00956700T
Other languages
English (en)
Inventor
David James Hallett
Michael Rowley
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Application granted granted Critical
Publication of ATE255109T1 publication Critical patent/ATE255109T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Exhaust Gas Treatment By Means Of Catalyst (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
AT00956700T 1999-09-07 2000-08-30 Imidazopyridinderivate als gaba rezeptor liganden ATE255109T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9921150.0A GB9921150D0 (en) 1999-09-07 1999-09-07 Therapeutic agents
PCT/GB2000/003350 WO2001018000A1 (en) 1999-09-07 2000-08-30 Imidazo-pyridine derivatives as ligands for gaba receptors

Publications (1)

Publication Number Publication Date
ATE255109T1 true ATE255109T1 (de) 2003-12-15

Family

ID=10860524

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00956700T ATE255109T1 (de) 1999-09-07 2000-08-30 Imidazopyridinderivate als gaba rezeptor liganden

Country Status (10)

Country Link
US (1) US6723735B1 (de)
EP (1) EP1214319B1 (de)
JP (1) JP2003508530A (de)
AT (1) ATE255109T1 (de)
AU (1) AU776815B2 (de)
CA (1) CA2384048A1 (de)
DE (1) DE60006835T2 (de)
ES (1) ES2209963T3 (de)
GB (1) GB9921150D0 (de)
WO (1) WO2001018000A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077605A1 (en) * 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
EP1854798A3 (de) * 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Kondensierte heterozyklische Succinimid-Verbindungen und Analoga daraus, Modulatoren der nuklearen Hormonrezeptorfunktion
GB0117277D0 (en) 2001-07-16 2001-09-05 Merck Sharp & Dohme Therapeutic agents
PA8535601A1 (es) 2000-12-21 2002-11-28 Pfizer Derivados benzimidazol y piridilimidazol como ligandos para gabaa
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US7087636B2 (en) * 2001-12-19 2006-08-08 Bristol-Myers Squibb Company Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
GB0208392D0 (en) * 2002-04-11 2002-05-22 Merck Sharp & Dohme Therapeutic compounds
EP2275095A3 (de) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenese durch modulation des Muscarinrezeptors
EP2258358A3 (de) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenese mit Acetylcholinesterasehemmer
EP1940389A2 (de) 2005-10-21 2008-07-09 Braincells, Inc. Modulation von neurogenese durch pde-hemmung
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US7425556B2 (en) 2005-12-20 2008-09-16 Astrazeneca Ab Compounds and uses thereof
US7465795B2 (en) 2005-12-20 2008-12-16 Astrazeneca Ab Compounds and uses thereof
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2382975A3 (de) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenese mittels Angiotensin-Modulation
JP2009536667A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド ５ｈｔ受容体介在性の神経新生
AU2007292848A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
HRP20150642T1 (hr) 2006-12-22 2015-08-14 Astex Therapeutics Limited BICIKLIÄŚKE HETEROCIKLIÄŚKE TVARI KAO INHIBITORI FGFR-a
US8513276B2 (en) 2006-12-22 2013-08-20 Astex Therapeutics Limited Imidazo[1,2-a]pyridine compounds for use in treating cancer
TW200911803A (en) * 2007-07-16 2009-03-16 Organon Nv 6-phenyl-1H-imidazo [4,5-c] pyridine-4-carbonitrile derivatives
GB0720041D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New Compounds
GB0720038D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New compounds
PT2307402E (pt) * 2008-04-29 2013-02-15 Novartis Ag Derivados de imidazo-piridina como inibidores de cinase semelhante ao recetor de ativina (alk4 ou alk5)
GB0810902D0 (en) 2008-06-13 2008-07-23 Astex Therapeutics Ltd New compounds
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
GB0906472D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
GB0906470D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
CA2951497C (en) 2014-06-12 2019-04-09 Pfizer Limited Imidazopyridazine derivatives as modulators of the gabaa receptor activity
BR112021004661A2 (pt) 2018-09-13 2021-06-01 Saniona A/S composto, composição farmacêutica, método para tratamento de dor neuropática e/ou prurido, e, uso do composto
WO2025141131A1 (en) 2023-12-27 2025-07-03 Saniona A/S A gabaa receptor ligand and the use thereof in medicine, in particular in the treatment of epilepsy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK40192D0 (da) * 1992-03-26 1992-03-26 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
AU675484B2 (en) * 1993-03-24 1997-02-06 Neurosearch A/S Benzimidazole compounds, their use and preparation
GB9702524D0 (en) * 1997-02-07 1997-03-26 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
DE60006835D1 (de) 2004-01-08
CA2384048A1 (en) 2001-03-15
WO2001018000A1 (en) 2001-03-15
GB9921150D0 (en) 1999-11-10
JP2003508530A (ja) 2003-03-04
US6723735B1 (en) 2004-04-20
AU6856700A (en) 2001-04-10
EP1214319A1 (de) 2002-06-19
ES2209963T3 (es) 2004-07-01
EP1214319B1 (de) 2003-11-26
AU776815B2 (en) 2004-09-23
DE60006835T2 (de) 2004-09-02

Similar Documents

Publication Publication Date Title
ATE255109T1 (de) Imidazopyridinderivate als gaba rezeptor liganden
ATE371659T1 (de) Pyrazolotriazinderivate als gaba-rezeptorliganden
ATE270672T1 (de) Imidazopyridinderivate als liganden für gaba- rezeptoren
WO2002002557A3 (en) 2-phenylimidazo[1,2-a]pyridine derivatives: a new class of gaba brain receptor ligands
NO990304L (no) Substituerte triazol-pyridazolderivater som ligander for GABA reseptorer
EA199700156A1 (ru) Производные индола как антагонисты рецептора 5-нт
WO2002050062A3 (en) Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
TR200400702T4 (tr) AMP özgü fosfodiesteraz inhibtörleri olarak 3-tiazol-4-il-pirolidin türevleri.
MXPA04000372A (es) Compuesto biciclicos de heteroarilo fusionados sustituidos con heteroarilo como ligandos del receptor gabaa.
ATE428694T1 (de) N-ä1h-indol-5-ylünaphthalin-1-sulphonamid- derivate und verwandte verbindungen als serotonin 5-ht6 rezeptor antagonisten zur behandlung von erkrankungen des zentralen nervensystems
WO2001034603A3 (en) Bicyclic and tricyclic heteroaromatic compounds
ATE338758T1 (de) Imidazopyrimidin-derivate als liganden für gaba- rezeptoren
ATE284403T1 (de) Triazolopyridazinderivate als liganden für gaba- rezeptoren
MA30631B1 (fr) Inhibiteurs de tyrosine kinase
ATE247639T1 (de) Arylsubstituierte cyclische amine als selektive dopamin-d3-liganden
MA31442B1 (fr) 3-(imidazolyl)-pyrazolo [3,4-b]pyridines
DE60307462D1 (de) 8-fluorimidazo(1,2-a)pyridin derivative als liganden für gaba rezeptoren
ATE247652T1 (de) 4-substituierte chinolinderivate als nk-3 und/oder gaba(a) rezeptor liganden
ATE253066T1 (de) Imidazotriazinderivate als gaba rezeptor-liganden
MA29643B1 (fr) Benzocycloheptapyridines comme inhibiteurs du recepteur tyrozine kinase met
ATE250062T1 (de) Triazolopiridazinederivate als gaba rezeptor- liganden
WO2004087690A3 (en) Benzimidazole derivatives and their use for modulating the gaba-a receptor complex
PT1023291E (pt) Derivados de dipiridoimidazole uteis no tratamento de desordens do sistema nervoso central
NO994527L (no) 2,3-dihydrofuro[3,2-b]pyridin, dets fremstilling og anvendelse derav i terapi
DE69907448D1 (de) Pyrido[2,3-b]indolizinderivate und aza analoge: crf1 spezifische liganden

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties